Architect SARS-CoV-2 IgG
Device
Abbott Laboratories
Total Payments
$462,337
Transactions
41
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $462,337 | 41 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $462,337 | 41 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Performance Evaluation of ARCHITECT SARS-CoV-2 IgG and IgM vs Alinity SARS-CoV-2 IgG and IgM assays | Abbott Laboratories | $131,198 | 0 |
| Longitudinal, Observational Registry of Persons Under Investigation for SARS-CoV2: The RUSH-COVID-19 Study | Abbott Laboratories | $130,000 | 0 |
| Sampling Employees at Rush University Medical Center and First Responders in Chicago for Evidence of SARS-CoV-2 Seroconversion (IgG and IgM) | Abbott Laboratories | $65,650 | 0 |
| Performance and Comparison Evaluation of ARCHITECT SARS-CoV-2 IgG Assay | Abbott Laboratories | $62,271 | 0 |
| Serum ImmunoGlobulin SIG-COVID investigation for COVID-19 healthcare workers at BMC | Abbott Laboratories | $31,947 | 0 |
| The COVID-19 FIRE Study: First-responder Immune Response Evolution after SARS-Cov-2 Exposure | Abbott Laboratories | $27,245 | 0 |
| Evaluation of ARCHITECT IgG Qualitative Performance on COVID-19 Convalescent Plasma Specimens & Controls | Abbott Laboratories | $8,728 | 0 |
| Evaluation of Oncology Patients for Evidence of SARS-CoV-2 IgG Seroconversion | Abbott Laboratories | $5,297 | 0 |
Top Doctors Receiving Payments for Architect SARS-CoV-2 IgG
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | South Boston, MA | $462,337 | 41 |
Ad
Manufacturing Companies
- Abbott Laboratories $462,337
Product Information
- Type Device
- Total Payments $462,337
- Total Doctors 0
- Transactions 41
About Architect SARS-CoV-2 IgG
Architect SARS-CoV-2 IgG is a device associated with $462,337 in payments to 0 healthcare providers, recorded across 41 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2020 to 2020. In 2020, $462,337 was paid across 41 transactions to 0 doctors.
The most common payment nature for Architect SARS-CoV-2 IgG is "Unspecified" ($462,337, 100.0% of total).
Architect SARS-CoV-2 IgG is associated with 8 research studies, including "Performance Evaluation of ARCHITECT SARS-CoV-2 IgG and IgM vs Alinity SARS-CoV-2 IgG and IgM assays" ($131,198).